{
    "nctId": "NCT00591864",
    "briefTitle": "Comparison of MRI and Molecular Breast Imaging in Breast Diagnostic Evaluation",
    "officialTitle": "Comparison of Magnetic Resonance Imaging and Molecular Breast Imaging in Breast Diagnostic Evaluation",
    "overallStatus": "COMPLETED",
    "conditions": "Breast Cancer",
    "studyType": "INTERVENTIONAL",
    "phase": "NA",
    "allocation": "NA",
    "primaryPurpose": "DIAGNOSTIC",
    "enrollmentCount": 89,
    "primaryOutcomeMeasure": "Sensitivity on the Per Patient Level",
    "eligibilityCriteria": "Inclusion Criteria:\n\n* This study will include a population of women aged 25 or older who are scheduled for a breast MRI examination at MAYO CLINIC ROCHESTER.\n* Patients must not be lactating or pregnant.\n* All women of child-bearing potential must have had a negative urine pregnancy test result within 2 days prior to the MBI study.\n* women who are scheduled for a breast MRI examination for a clinical concern, problem solving or for further evaluation of invasive breast cancer (e.g. pre-operative staging of known breast cancer).\n\nExclusion Criteria:\n\n* They are unable to understand and sign the consent form\n* They are pregnant or lactating\n* They are physically unable to sit upright and still for 40 minutes.\n* The breast MRI is for screening purposes or to determine the status of breast augmentation.\n* They have undergone breast surgery within the previous year",
    "sex": "FEMALE",
    "minimumAge": "25 Years",
    "stdAges": "ADULT, OLDER_ADULT"
}